HCID 10173874, compound → HCID 58765845, compound
Reaction equation
[CH3:1][C:2]1[CH:7]=[C:6]([O:8][CH:9]([C:13]2[O:17][C:16]([C:18]3[CH:23]=[CH:22][C:21]([C:24]([F:27])([F:26])[F:25])=[CH:20][CH:19]=3)=[N:15][C:14]=2[CH3:28])[CH2:10][CH:11]=[CH2:12])[CH:5]=[CH:4][C:3]=1[CH2:29][CH2:30][C:31]([OH:33])=[O:32]>[Pd].O1CCCC1>[CH3:1][C:2]1[CH:7]=[C:6]([O:8][CH:9]([C:13]2[O:17][C:16]([C:18]3[CH:23]=[CH:22][C:21]([C:24]([F:27])([F:26])[F:25])=[CH:20][CH:19]=3)=[N:15][C:14]=2[CH3:28])[CH2:10][CH2:11][CH3:12])[CH:5]=[CH:4][C:3]=1[CH2:29][CH2:30][C:31]([OH:33])=[O:32]Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
3-(2-Methyl-4-{1-[4-methyl-2-(4-trifluoromethyl-phenyl)-oxazol-5-yl]-but-3-enyloxy}-phenyl)-propionic acid (30 mg, 0.065 mmol), 10% Palladium on charcoal (30 mg) and tetrahydrofuran (30 mL) is stirred under a hydrogen balloon 30 min. The solution is filtered over celite and concentrated in vacuo to afford the title compound, 3-(2-Methyl-4-{1-[4-methyl-2-(4-trifluoromethyl-phenyl)-oxazol-5-yl]-butoxy}-phenyl)-propionic acid as a white solid, 30 mg 100%. MS (M++1) 462.
Workup
- filtrationThe solution is filtered over celite and
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-2647ec1c17d54937ae69ed7a060bcaf5
- Source dataset
- uspto-grants-2006_12
- Patent number
- US07153878B2
Reaction notes
Loading…